NRAS and cancer: Particularly, one of these exons (Ensembl ID: ENSE00001751295.1, exon 3) (Figure 5) accumulates mutations in 4052 patients, which accounts for over 60% of the total number of cancer patients with at least one annotated mutation in NRAS.